Champions Oncology (CSBR) Goodwill & Intangibles (2011 - 2026)
Champions Oncology (CSBR) posted quarterly Goodwill & Intangibles of $335000.0 for Q2 2026, little changed year-over-year from $335000.0 in Q2 2025, and little changed quarter-over-quarter from $335000.0 in Q1 2026.
Champions Oncology (CSBR) Goodwill & Intangibles (2011 - 2026) Analysis & Trends
Champions Oncology's Goodwill & Intangibles history runs 16 years deep, the most recent figure standing at $335000.0 for Q2 2026.
- In Q2 2026, Goodwill & Intangibles changed 0.0% year-over-year to $335000.0; the TTM figure through Apr 2026 stood at $335000.0 (changed 0.0% YoY), while the FY2026 annual figure was $335000.0, changed 0.0% from the prior year.
- Goodwill & Intangibles for Q2 2026 stood at $335000.0, roughly flat from $335000.0 in the prior quarter.
- The five-year high for Goodwill & Intangibles was $2.2 million in Q1 2022, with the low at $335000.0 in Q2 2022.
- The 5-year median for Goodwill & Intangibles is $335000.0 (2022), against an average of $440555.6.
- The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles surged 567.16% in 2022, then tumbled 85.01% in 2023.
- Champions Oncology's Goodwill & Intangibles stood at $335000.0 in 2022, then changed by 0.0% to $335000.0 in 2023, then changed by 0.0% to $335000.0 in 2024, then changed by 0.0% to $335000.0 in 2025, then changed by 0.0% to $335000.0 in 2026.
- Business Quant data shows CSBR's Goodwill & Intangibles at $335000.0 in Q2 2026, $335000.0 in Q1 2026, and $335000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Champions Oncology | 68.61 Mn | 68.61 Mn | 7.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 335,000.00 |
| Jan 31, 2026 | 335,000.00 |
| Oct 31, 2025 | 335,000.00 |
| Jul 31, 2025 | 335,000.00 |
| Apr 30, 2025 | 335,000.00 |
| Jan 31, 2025 | 335,000.00 |
| Oct 31, 2024 | 335,000.00 |
| Jul 31, 2024 | 335,000.00 |
| Apr 30, 2024 | 335,000.00 |
| Jan 31, 2024 | 335,000.00 |
| Oct 31, 2023 | 335,000.00 |
| Jul 31, 2023 | 335,000.00 |
| Apr 30, 2023 | 335,000.00 |
| Jan 31, 2023 | 335,000.00 |
| Oct 31, 2022 | 335,000.00 |
| Jul 31, 2022 | 335,000.00 |
| Apr 30, 2022 | 335,000.00 |
| Jan 31, 2022 | 2.24 Mn |
| Oct 31, 2021 | 335,000.00 |
| Jul 31, 2021 | 335,000.00 |